Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRWS Holdings Regulatory News (RWS)

Share Price Information for RWS Holdings (RWS)

Share Price is delayed by 15 minutes
Get Live Data
105.00    0.50 (0.48%)
Bid:
103.00
Ask:
104.70
Spread: 1.70 (1.65%)
Market Cap: £389.72m
RWS Live PriceLast checked at - London Stock Exchange

Intraday RWS Holdings Share Chart

Acquisition

12 Jul 2023 09:30

RNS Number : 7836F
RWS Holdings PLC
12 July 2023
Β 

Β 

For immediate release 12 July 2023

Β RWS Holdings plc

Acquisition of Propylon Holdings Ltd

Β 

RWS Holdings plcΒ ("RWS" or the "Group"), a unique world-leading provider of technology-enabled language, content and intellectual property services, announces that it has acquiredΒ Propylon Holdings Ltd ("Propylon") for €30.1 million ($33.1 million) on a cash-and-debt free basis with additional deferred payments of €6.45 million ($7.1 million) due on each of the first and second anniversary of completion, conditional on the Propylon management team remaining in place.

Propylon's component content management system ("CCMS") is used by governments, standards bodies, legal publishers and regulated firms to address the complexities involved with drafting, managing, publishing and updating legal and legislative content. Its unique user-friendly solution allows authoring in its CCMS through Microsoft Word. Clients include a number of US State legislatures and national parliaments. In addition, Propylon also provides software to a range of standards bodies and global regulated professional services organisations, who will benefit from RWS's integrated localization capabilities.

The acquisition aligns with the Group's strategy to serve the regulated and legal markets and also strengthens RWS's commitment to innovation in structured content management.

Headquartered in Dublin, Ireland, Propylon will continue to be managed by its current CEO, John Harrington, who will further build on the company's strong record of year-on-year revenue growth and strong cash generation from a growing list of clients with multi-year contracts. In the year ended 31 Dec 2022, Propylon reported revenue of $12.7m, a 13.4% increase from the previous year and is expected to deliver revenue growth for the year ending 31 December 2023 of approximately 30% with an EBITDA margin close to 25%. The company, founded in 1999, has approximately 100 employees based in Ireland and the US.

The acquisition will be funded from RWS's existing cash resources and bank facilities and is in line with the Group's strategy to actively pursue acquisitions that have the potential to accelerate delivery of its medium-term plans.

Ian El-Mokadem, Chief Executive Officer of RWS, commented:

"Propylon is a pioneer in its industry and has hugely helped its clients to manage the way they author, publish and comply with laws and regulations. The synergies between our organisations come from our ability to combine offerings, expand our geographical reach and bring new propositions to our global client base. Today's announcement supports our medium to long-term growth strategy and signals our intention to remain at the forefront of the structured content market."

For further information, please contact:

RWS Holdings plc

Andrew Brode, Chairman

Ian El-Mokadem, Chief Executive Officer

Candida Davies, Chief Financial Officer

Β 

Β 

Β 

01753 480200

Β 

MHP (Financial PR Advisor)

Katie Hunt / Eleni Menikou / Catherine Chapman

Β 

rws@mhpgroup.com

020 3128 8100

07884 494112

Β 

Numis (Nomad & Joint Broker)

Stuart Skinner / Kevin Cruickshank / Will Baunton

Β 

Β 

Β 

020 7260 1000

Β 

Berenberg (Joint Broker)

Ben Wright / Toby Flaux / Alix Mecklenburg-Solodkoff

Β 

020 3207 7800

Β 

About RWS RWS Holdings plc is a unique, world-leading provider of technology-enabled language, content and intellectual property services. Through content transformation and multilingual data analysis, our combination of AI-enabled technology and human expertise helps our clients to grow by ensuring they are understood anywhere, in any language.

Β 

Our purpose is unlocking global understanding. By combining cultural understanding, client understanding and technical understanding, our services and technology assist our clients to acquire and retain customers, deliver engaging user experiences, maintain compliance and gain actionable insights into their data and content.

Β 

Over the past 20 years we've been evolving our own AI solutions as well as helping clients to explore, build and use multilingual AI applications. With 40+ AI-related patents and more than 100 peer-reviewed papers, we have the experience and expertise to support clients on their AI journey.

Β 

We work with over 80% of the world's top 100 brands, more than three-quarters of Fortune's 20 'Most Admired Companies' and almost all of the top pharmaceutical companies, investment banks, law firms and patent filers. Our client base spans Europe, Asia Pacific and North and South America. Our 65+ global locations across five continents service clients in the automotive, chemical, financial, legal, medical, pharmaceutical, technology and telecommunications sectors.

Founded in 1958, RWS is headquartered in the UK and publicly listed on AIM, the London Stock Exchange regulated market (RWS.L).

For further information, please visit: www.rws.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
ACQKZGMNNZDGFZG
Date   Source Headline
1st Oct 20257:00 amRNSTotal Voting Rights
1st Sep 20253:09 pmRNSTotal Voting Rights
28th Aug 20257:00 amRNSHolding(s) in Company
18th Aug 20257:00 amRNSHolding(s) in Company
8th Aug 202511:11 amRNSHolding(s) in Company
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 20257:00 amRNSDirector/PDMR Shareholding
28th Jul 20259:25 amRNSHolding(s) in Company
23rd Jul 20254:29 pmRNSHolding(s) in Company
18th Jul 20251:19 pmRNSHolding(s) in Company - amendment
16th Jul 20254:01 pmRNSHolding(s) in Company
2nd Jul 20259:00 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSTotal Voting Rights
30th Jun 20257:00 amRNSChange of Nominated Adviser
26th Jun 202511:00 amRNS-RAcquisition of IP of Papercup
23rd Jun 202510:46 amRNSHolding(s) in Company
18th Jun 202512:30 pmRNSHolding(s) in Company
18th Jun 202510:12 amRNSHolding(s) in Company
17th Jun 202511:29 amRNSFurther re Half Year Report
17th Jun 20257:00 amRNSHalf-year Report
11th Jun 20257:00 amRNSHolding(s) in Company
10th Jun 20257:00 amRNSHolding(s) in Company
6th Jun 20257:00 amRNSHolding(s) in Company
2nd Jun 20257:00 amRNSTotal Voting Rights
12th May 20259:15 amRNS-RAppointment of Chief Product & Technology Officer
8th May 202511:51 amRNSDirector/PDMR Shareholding
6th May 202510:10 amRNSHolding(s) in Company
2nd May 20259:15 amRNSHolding(s) in Company
1st May 20252:15 pmRNSDirector/PDMR Shareholding
1st May 20257:00 amRNSTotal Voting Rights
30th Apr 20257:00 amRNSHolding(s) in Company
29th Apr 20257:00 amRNSHolding(s) in Company
28th Apr 20257:00 amRNSHolding(s) in Company
25th Apr 20257:00 amRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSTrading Statement
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 20257:00 amRNSChange of Registered Office
3rd Mar 20258:55 amRNSTotal Voting Rights
14th Feb 20253:51 pmRNSHolding(s) in Company
13th Feb 202512:33 pmRNSDirector/PDMR Shareholding
11th Feb 202512:14 pmRNSResult of AGM
11th Feb 20257:00 amRNSAGM Statement
10th Feb 20254:57 pmRNSHolding(s) in Company
3rd Feb 20255:00 pmRNSDirector/PDMR Shareholding
3rd Feb 20254:58 pmRNSDirector/PDMR Shareholding
3rd Feb 20257:00 amRNSTotal Voting Rights
28th Jan 20252:06 pmRNSDirector/PDMR Shareholding
28th Jan 20252:04 pmRNSDirector/PDMR Shareholding
28th Jan 20252:01 pmRNSDirector/PDMR Shareholding
23rd Jan 20253:58 pmRNSOption Exercise, Admission and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.